www.fdanews.com/articles/196136-cryolifes-hybrid-stent-graft-nabs-mark
CryoLife’s Hybrid Stent Graft Nabs Mark
March 5, 2020
CryoLife’s E-vita Open NEO hybrid stent graft system has earned CE Mark certification for treating aortic arch disease.
The hybrid stent graft allows surgeons to use a one-stage procedure for treating the condition by combining surgical arch repair with endovascular descending thoracic repair.
The device features a tri-branched vessel that reduces surgical time while improving the safety of the procedure.